Department of Epidemiology, The University of Texas, MD Anderson Cancer Centre
Joe HARFORD, Ph.D.
Director of Office of International Affairs, NCI, USA
Musa MAYER, M.S., M.F.A
She is a 19-year survivor, advocate and author of three books and many articles on breast cancer. "Understanding Evidence-Based Healthcare: A Foundation for Action," her six-module web training course for advocates, was co-developed with Kay Dickersin, Director of the U.S. Cochrane Center at www.Cochrane.us She has served on several FDA advisory committees, and on an Institute of Medicine forum. As an advocate for a Department of Defense Center of Excellence grant on breast cancer brain metastases, she and fellow advocate Helen Schiff developed a website for patients www.BrainMetsBC.org She provides daily information and support on-line for women with metastatic breast cancer at www.bcmets.org and her web resource for women with advanced breast cancer can be found at www.AdvancedBC.org
Sofia D. MERAJVER, M.D., Ph.D.
Professor of Internal Medicine and Scientific Director, Breast Cancer Research Program
Director Breast and Ovarian Cancer Risk Evaluation Program at University of Michigan, Comprehensive Cancer Centre - USA.
Clinical Interests: Breast Cancer treatment and genetic risk assessment and counseling. Breast and ovarian cancer risk and evaluation, inflammatory breast cancer, angiogenesis, and locally advanced breast cancer. Research Interests: Molecular genetics of breast cancer, BRCA1 gene function, angiogenesis, cancer risk assessment.
Shahla MASOOD, M.D.
Chief Pathologist, Department of Pathology and Laboratory Medicine, University of Florida, College of Medicine, Jacksonville, FL,USA.
Founder of the International Society for Breast Pathology, and founder and editor-in-chief of Breast Journal. Dr. Masood is steering committee member for the Breast Health Global Initiative.
Selma MORRIS, M.ED.
International Health Consultant
Board member of Intercultural Cancer Council (ICC)
Amr S. SOLIMAN, M.D., Ph.D.
Associate Professor of Epidemiology, University of Michigan, School of Public health, Ann Arbor, Michigan. Director, Cancer Epidemiology Education in Special Populations Program, University of Michigan School of Public Health, and Cancer Center, NCI, USA.
Dr. Soliman's research is focused on international cancer epidemiology. He has developed multidisciplinary molecular and genetic epidemiologic investigations into pancreatic, breast, and colorectal cancers in different ethnic and racial groups through national and international comparative studies. Furthermore, he is exploring the effect of migration to the United States on cancer risk modification. These studies are being pursued through interaction and collaboration with clinicians and scientists in the U. S. as well as international institutions in Egypt, Jordan, Tunisia, Morocco, Tanzania, Turkey, India and other countries in the Middle East and Africa.
President, Reach to Recovery International (RRI), South Africa since Stockholm conference 2007.
Ann started attending Reach to Recovery meetings after she was diagnosed with breast cancer in 1990. Two years later, she trained as a Reach to Recovery volunteer. In 1995, Ann began to develop a training programme relevant to the national context. “South Africa is a country of diverse communities,” she says. “I saw a need for greater support right across these communities. Breast cancer affects us all and has joined together women from these various communities. It is hard to say how many volunteers I have trained –certainly over 200.” Ann has also served as the African regional representative on the RRI committee. With the help of a grant from Susan G Komen for the Cure, she has been able to train volunteers from 14 African countries. In 2005, Ann Steyn received the Terese Lasser award in recognition of her contribution to the development of the RRI programme in Southern Africa.